Influence of novel oral anticoagulants on anticoagulation care management

Janzic, Andrej; Kos, Mitja

doi:10.1515/acph-2017-0030

Cited by 2 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The research team consisted of four researchers working in an academic environment: two researchers and faculty professors, a researcher with a PhD in pharmacoeconomics and a second-year doctoral student. The researchers are familiar with qualitative study designs and have conducted several focus panels and other types of qualitative studies [3,4,5].…”

Section: Research Teammentioning

confidence: 99%

Regulatory and clinical perspective on patient access to antidiabetic medicines in Slovenia

et al. 2021

Self Cite

View full text Add to dashboard Cite

Introduction/Objective. Three novel classes of antidiabetic medicines have been introduced to the market in the last decade, namely dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 analogues and sodium-glucose co-transporter 2 inhibitors. There are many factors that influence patient access to these medicines and their utilization in clinical practice that need to be explored. The aim of the study was to gain an insight into patient access to antidiabetic medicines in Slovenia from a regulatory and clinical point of view. Methods. A focus group with five Slovenian experts (representatives of regulatory bodies and prescribers of antidiabetic medicines) was performed in January 2019. The discussion was audiotaped upon obtaining written consent from the experts and transformed into a verbatim transcript. Two researchers independently analyzed the content of the discussion, using NVivo 11 to identify main themes and subthemes. Results. Slovenia provides satisfactory patient access to antidiabetic medicines; however, prescribing restrictions and unequal access to diabetologists in the Slovenian regions may limit patient access to novel antidiabetic medicines. Prescribing restrictions should be aligned with the new evidence on cardiovascular benefit of some antidiabetic medicines. A national registry of patients with diabetes should be established in order to obtain reliable data on patient outcomes and improve the quality of patient care. Conclusion. Patient access to antidiabetic medicines not only in Slovenia but also in other countries could be improved by changing prescribing restrictions, establishment of national registries of patients with diabetes and involvement of multidisciplinary teams in diabetes care.

show abstract

Section: Research Teammentioning

confidence: 99%

Regulatory and clinical perspective on patient access to antidiabetic medicines in Slovenia

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…Currently, DOACs are the dominant OAC in many countries 16 . Although DOACs are said to require less monitoring, they still require the same orientation to their benefit, harms, adherence, procedures, drug coverage and duration 17 . The aim of patient education is to enable ‘individuals to make informed decisions about their personal health‐related behaviour’ 18 .…”

Section: Introductionmentioning

confidence: 99%

“…16 Although DOACs are said to require less monitoring, they still require the same orientation to their benefit, harms, adherence, procedures, drug coverage and duration. 17 The aim of patient education is to enable 'individuals to make informed decisions about their personal health-related behaviour'. 18 Several educational theories have provided a framework of patient education, but defining the optimal content components, appropriate format, timing and duration is still an unmet goal in OAC patient education.…”

Section: Introductionmentioning

confidence: 99%

Perceptions of patients and healthcare providers on patient education to improve oral anticoagulant management

Mei

Swinton

Troyan

et al. 2022

Evaluation Clinical Practice

View full text Add to dashboard Cite

Rationale and Objectives Education of patients is thought to be key to high‐quality oral anticoagulant (OAC) medication management. Theoretically, improving patients' knowledge should improve their self‐management skills and adherence. The study's objective was to explore the opinions of healthcare providers and patients on the desired content and format of patient education on OACs, in addition to perceived barriers to high‐quality patient education. Methods We applied qualitative descriptive methods in a focus group study on OAC management. Five focus group discussions were conducted in two health regions in Southwestern Ontario from 2017 to 2018 with 19 patients, 7 caregivers and 16 healthcare providers (physicians, nurses and pharmacists). During the focus groups, participants discussed their experiences with OAC education and made suggestions about the content and format for patient education on OACs. Transcripts were analysed using conventional content analysis. Results We identified the five themes of patient education on OAC management: content of OAC education (rationale, risk and appropriate drug administration methods), the best times for providing OAC education (time of OACs initiation along with continuing education), preferred education delivery strategies (case management targeted patient information summaries from authoritative sources such as Thrombosis Canada and video education), patient and community pharmacist engagement in OAC education, and perceived barriers to optimal patient education (patients depending too much on their healthcare providers for advice, the limited time patients spend with healthcare providers, gaps in clear communication between providers and the lack of a nationally or provincially coordinated OAC management programme). Conclusion Our findings suggest that patients, caregivers and healthcare providers support the need for education on OACs, including for patients taking DOACs. Specific important content and proper education format are needed. The optimal combination of content, format, duration, timing and sources for OAC education requires further research.

show abstract

Influence of novel oral anticoagulants on anticoagulation care management

Cited by 2 publications

References 13 publications

Regulatory and clinical perspective on patient access to antidiabetic medicines in Slovenia

Regulatory and clinical perspective on patient access to antidiabetic medicines in Slovenia

Perceptions of patients and healthcare providers on patient education to improve oral anticoagulant management

Contact Info

Product

Resources

About